Skip to content
value.today

Thrive Therapies Group, Inc.

🇺🇸 Nashville, Tennessee, USAHealth CareFounded 2023

Formerly Thrive Therapies Group, LLC

Total raised
$2 M
1 round on record
Latest round
$2 M
May 2026
First round on record
May 2026
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Thrive Therapies Group, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2026$2 MNo. 1Under $2 million

Thrive Therapies Group, Inc.: Raise no. 1, May 2026

Investors in this round

3 investors had bought by the notice of Jun 25, 2026: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $7 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kristin McGraner · Executive Officer, Director
  • Krishna Srinivasan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kristin McGraner, Chief Executive Officer. Newest notice filed Jun 25, 2026. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Thrive Therapies Group, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2026).

    SEC Form D · Jun 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Thrive Therapies Group, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Thrive Therapies Group, Inc.
NameRoleNamed in
Kristin McGranerExecutive officerJun 2026
Krishna SrinivasanDirectorJun 2026
Kristin McGranerDirectorJun 2026